"ResMed profit jumps after rival’s own goal
Share
Sleep disorder and breathing devices company ResMed had a $US250 million ($350 million) windfall gain in 2022, thanks to an own goal by its rival Philips which was forced to recall some of its devices over a risky component in June last year.
It helped propel ResMed to a 12 per cent increase in full-year revenue to $US3.6 billion, while net profit hit $US779.4 million, up 64 per cent."
Full article https://www.copyright link/companie...-jumps-after-rival-s-own-goal-20220811-p5b96x
Swift
- Forums
- ASX - By Stock
- RAP
- Timely Information
Timely Information
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online